Market Research Blog

According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices market will rise. Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders.

Government initiatives supported by public and private organizations to spread awareness has led people to focus on early diagnosis of medical conditions to avoid delay in treatment. Furthermore, a number of players are developing new products to expand their product portfolio as well as to maintain their position in the market.

For an instance Olympus has launched a few unique pulmonology devices such as the flexible bronchoscope that has helped the company in maintaining its position in the market. A large number of domestic players are slowly emerging in Asia Pacific. Rise in healthcare expenditure in developing countries and improving reimbursement policies are causing shift in focus among market players from developed to developing countries.

Moreover, the availability of pulmonology devices for healthcare professionals has been impacted by COVID-19 supply chain crisis. However, there are measures taken to manage this situation. Governments have relaxed controls to make supply easy. Export controls have been made easy by several manufacturing countries.

Major manufacturers in the pulmonology devices market are geared up and focusing on local production of pulmonology devices. According to the report, the increasing cases COPD and lung cancer will continue fuelling demand in the market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Key Takeaways from pulmonology devices Marker Study

• The demand for pulmonology devices is expected to get higher, enabling the market to exhibit 10.8% CAGR between 2020 and 2030
• Backed by increasing healthcare spending, the U.S. is expected to account for nearly 90% sales in North America
• Favorable reimbursement policies will enable the U.K. to exhibit 13% y-o-y growth in 2021
• Germany and France will showcase increasing investment towards expanding healthcare infrastructure, in turn fuelling the demand for pulmonology devices
• Within East Asia, Japan and South Korea will represent highly attractive markets for sale

Who is Winning?

Leading players in the pulmonology devices market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

• In February 2019, the Conmed Corporation acquired privately-held Buffalo Filter LLC, a leader in surgical smoke evacuation technologies. The company’s comprehensive product portfolio includes smoke evacuation pencils, smoke evacuators, and laparoscopic solutions.
• In November 2019, Cook Medical opened new facility in India. This office enables the company to expand its business in emerging markets.
• In January 2019, the Verathon, Inc launched GlideScope® BFlex, a single-use flexible bronchoscope that offers optimal visibility and maneuverability for routine airway and bronchoscopy procedures.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13036

Pulmonology devices Market by Category

Product

• Pulmonary Biopsy Devices
  • Single- Use Biopsy Forceps
  • Cytology Brushes
  • Microbiology Brushes
• Endobronchial Ultrasound (EBUS) Needles
  • Endobronchial Ultrasound Fine Biopsy Needles
  • Endobronchial Ultrasound Transbronchial Aspiration Needles
• Airway Stents
  • Silicon Stents
  • Nitinol Stents
  • Stainless Steel Stents
• Airway Extraction Baskets
• Single-Use Bronchoscopes

Indication

• Lung Cancer
• COPD
• Foreign Body Extraction
• Tracheal and Bronchial Stenosis
• Others

End User

• Hospitals
• Pulmonology Clinics
• Ambulatory Surgical Centers

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

3.3. Disease Epidemiology, By Region

3.4. Technology Assessment Vs. Application

3.5. Regulatory Scenario

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-13036

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

A recent market study published by Future Market Insights (FMI) on the Autoclaves market offers global industry analysis for 2015–2019 & opportunity assessment for 2020–2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Autoclaves market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the autoclaves market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the autoclaves market in the coming years. The report provides detailed information about the current and future growth prospects of the autoclaves market in the most comprehensive way for better understanding of readers.

Key Segments of Autoclaves Market

FMI’s study on the Autoclaves market offers information divided into six important segments — Product, Modality, Loading, Chamber, End User and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12890

Report Chapter

Executive Summary

The report commences with the executive summary of the autoclaves market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the autoclaves market as well as the key trends impacting the market.

Market Overview

Readers can find detailed taxonomy and product definition of the autoclaves market, in this chapter, which help readers understand basic information about autoclaves.

Key Market Trends

This section highlights the key trends impacting the autoclaves market, which will help readers understand the current trends and their impact on market growth.

Key Success Factors

This chapter explains the pipeline assessment, key regulations for product launch in various countries along with disease epidemiology that are expected to influence the growth of the autoclaves market during the forecast period.

Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the autoclaves market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the autoclaves market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the autoclaves market, as well as those that are likely to hamper the growth of the autoclaves market. The opportunity analysis for the autoclaves will help readers understand the market opportunities, based on which they can plan their strategies.

Inquire Before Buying this research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12890

Global Autoclaves Market Value (US$) Analysis 2015–2019 and Forecast 2020–2030

This section explains the global market value analysis and forecast for the autoclaves market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the Autoclaves Market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
• Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The transradial closure devices market is growing with the increasing cases of cardio vascular diseases all over the world. A new study by Future Market Insights (FMI) has projected the market to rise at 6.8% CAGR between 2022 and 2030. According to the report, demand will rise consistently on the back of surging cases of cardiovascular ailments caused by stress, unhealthy lifestyle, and others factors.

According to World Health Organization (WHO), every year cardiovascular diseases cause an estimated 31% of death occurring worldwide. Also a 2016 Heat Disease and Stroke Statistics update by the American Heart Association stated that over 15 million people in the U.S. have coronary heart disease.

With no signs of the incidence slowing down, the demand for procedures such as angiography, angioplasty, percutaneous coronary intervention (PCI), and others will continue rising. Consequently, the demand for transradial closure devices is surging rapidly all over the world.

Radial access is highly efficient in providing faster mobility to patients due to smaller incision.  Furthermore, chances of infection at site is lower in radial access as compared to transfemoral access, which makes it highly preferred by diverse end users, starting from hospitals to specialized clinics.

The outbreak of COVID-19 pandemic is anticipated to impact the market negatively. The temporary period of lull could continue until the next year. However, the transradial closure devices market has high potential to grow further in the coming years.

FMI offers an exhaustive overview of the transradial closure devices market, its growth drivers, and restraints.

“Due to the rising cases of cardio vascular diseases, there has been increase in surgical and diagnostic procedures related to it. Transradial access (RA) being associated with less complications, is highly preferred by the various end users such as ambulatory surgical centers, hospitals, and others. In the coming years, the uptake of transradial closure devices will therefore rise especially since patients are increasingly willing to spend on procedures that ensure shorter hospital stays,” says an FMI analyst.

Some of the key takeaways from the report are highlighted below-

• Band or strap based transradial closure type devices are expected to lead in the market during the forecast period
• Disposable devices are anticipated to gain traction in terms of usage
• Application of transradial devices in diagnostic segment will remain high throughout the forecast period
• Among the end users, independent catheterization centres will emerge dominant in the coming years
• North America will lead in the global market followed by Europe

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12841

 

COVID-19 Impact Analysis

Due to the outbreak of COVID-19 pandemic, manufacturing process of transradial closure devices was hampered during the lock down. Contrary to this, novel coronavirus might cause cardiovascular concerns, which has resulted in surge in demand for the transradial closure devices in hospitals, specialized clinics, and other segments.

As per the latest study by FMI, the global transradial closure devices market has high potential to overcome the threats posed by the ongoing pandemic and grow further in the coming years.

Who is Winning

The global transradial closure devices market is highly competitive. In order to strengthen their foothold market players are focusing on the launch of ultra-modern transradial closure devices.

For instance, Comed B.V has launched their new Io Radial Compression Tourniquet (IoRACT) which is effective to compress the radial artery puncture, post procedure in the current year. Their IoRACT is small, and especially designed to optimize compression, view the puncture side and deflate the compression balloon.

Merit Medical, Inc. has launched their exclusive PreludeSYNC Radial Compression Device which assists in achieving vascular hemostasis in the recent year. Their PreludeSYNC Radial Compression Device is available with the safety and convenience of a specialized connection device and syringe.

More Valuable Insights on Transradial Closure Devices Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global transradial closure devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (band/strap based, knob based, plate based), usage (disposable device, reusable device), application (surgical intervention, diagnostics), end user (hospitals, independent catheterization centers, ambulatory surgical centers, specialized clinics), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12841

Key Segments Of Transradial Closure Devices Industry Survey

Transradial Closure Devices Market by Product:

• Band/Strap-based Transradial Closure Devices
• Knob-based Transradial Closure Devices
• Plate-based Transradial Closure Devices

Transradial Closure Devices Market by Usage:

• Disposable Transradial Closure Devices
• Reusable Transradial Closure Devices

Transradial Closure Devices Market by Application:

• Surgical Intervention
• Diagnostics

Transradial Closure Devices Market by End User:

• Hospitals
• Independent Catheterization Centers
• Ambulatory Surgical Centers
• Specialized Clinics

Transradial Closure Devices Market by Region:

• North America Transradial Closure Devices Market
• Latin America Transradial Closure Devices Market
• Europe Transradial Closure Devices Market
• East Asia Transradial Closure Devices Market
• South Asia & Pacific Transradial Closure Devices Market
• Middle East & Africa (MEA) Transradial Closure Devices Market

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12841

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

In its new market study, Future Market Insights (FMI) estimates global cell culture media bags market will register impressive growth between 2020 and 2030, progressing at a stellar CAGR of 10.8%. Furthermore, the study projects that the market will surge past a global valuation of US$ 2.67 Bn by 2030. The report attributes the growth of the market to soaring demand for disposable packaging solutions in life sciences R&D activities and manufacturing of biopharmaceuticals.

Moreover, the emergence of innovative techniques such as four-layered films, which provide exceptional oxygen and moisture barrier properties, is also expected to boost demand.

Having analyzed the impact of the COVID-19 pandemic, the report opines that increasing health concerns and high emphasis on biopharmaceutical research will augur well for market growth during the assessment period.

COVID-19 Impact

The outbreak of COVID-19 is expected to positively influence the demand for cell culture media bags as players operating in the healthcare and pharmaceutical sectors emphasize on high quality and safe packaging and storing solutions. Moreover, an upsurge in the number of studies and researches during the pandemic to develop a vaccine is, in turn, propelling demand for cell culture media bags.

Likewise, the need for disposable and single-use solutions for applications such as large-scale purification, cell storage, protein purification, and polishing applications in the biopharmaceutical market will continue to offer remunerative opportunities to market players through the pandemic period.

List Of Key Players Covered in Cell Culture Media Bags Market are:

• Parker Hannifin Corp
• Pall Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Inc.

Competitive Landscape:

In this fast-growing industry, partnerships and collaborations, product launches, expansions, and other strategies have been used to gain a major piece of the cell culture media bags market.

To meet the increased demand for bioprocess manufacturing activities, market participants are concentrating on up-scaling media bag production. In addition, producers are tackling problems and improved features of bags such as four-layered films that provide stronger oxygen and moisture barriers to the properties.

In this vein, Thermo Fisher Scientific released the CEDIA Mitragynine (Kratom) Assay, a novel immunoassay for kratom alkaloid mitragynine screening designed specifically for criminal justice and forensic purposes.Throughout the projection period, continuous product innovations will continue to define the competitive landscape of the market. Furthermore, industry participants are concentrating their efforts on producing products for specific end uses.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-12670

Key Takeaways

• 2D bag designs are expected to account for over half of the market value, owing to their high flexibility
• Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
• By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
• Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
• US will remain the largest market for cell culture media bags globally.

“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks FMI analyst.

Who is Winning?

Cell culture media bags manufacturers are focusing on developing solutions that address the key challenges such as recycling of multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.

• In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
• In August, 2015, Rim Bio partnered with Playmouth based Sentrol for sales and distribution of its single-use bio containers across the United States.

FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorious AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.

Key Segments:

Cell Culture Media Bags Market by Bag Size:

• Very Small Bags (< 150 ml)
• Small Bags (151 – 500 ml)
• Medium Sized Bags (501 – 1000 ml)
• Large Bags (1001- 3000 ml)
• Very Large Bags (>3000 ml)

 Cell Culture Media Bags Market by Application:

• Storage
• Mixing
• Processing
• Gas Exchanges
• Heat Transfer
• Turbidity
• Flow Rate Monitoring
• Pressure
• Viscosity

 Cell Culture Media Bags Market by Host Cell:

• Mesenchymal Cells
• Plant Cells
• Insect Cells
• Bacteria Cells
• Yeast Cells
• Chinese Hamster Ovary
• Baby Hamster Kidney

Cell Culture Media Bags Market by Bag Design:

• 2D Cell Culture Media Bags
• 3D Cell Culture Media Bags

Cell Culture Media Bags Market by End Use:

• Life Science R&D
• Biopharmaceutical Manufacturers

Cell Culture Media Bags Market by Region:

• North America Cell Culture Media Bags Market
• Latin America Cell Culture Media Bags Market
• Europe Cell Culture Media Bags Market
• East Asia Cell Culture Media Bags Market
• South Asia & Pacific Cell Culture Media Bags Market
• Middle East & Africa (MEA) Cell Culture Media Bags Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12670

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032).

Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years.  Cancer immunotherapy is emerging as a new avenue for the development of biomarker testing, thereby augmenting the growth in the market.

Rising technological advancements in immunotherapy are propelling the adoption PD-L1 biomarker testing for non-small cell lung cancer as an effective means for therapeutic usage of PD-L1 proteins for benign lesions or tumor identification.

Moreover, the unmet needs of cancer treatments are addressed by the growing availability of high-quality immunotherapy products worldwide. Lifestyle changes, such as physical inactivity, tobacco consumption and smoking, as well as unhealthy diet are prime factors responsible for the growing burden of cancerous indications in the current scenario.

The emergence of cancer immunotherapy has advanced the diagnostic approach to cancer detection and management, thus propelling the growth in the PD-L1 biomarker testing market.

Key players operating in the market space are focusing on the development or extension of novel biologics using existing biologic resources for innovative product identification and provision of patented therapies.

Furthermore, the occurrence of adverse conditions such as organ failure and relapse into cancer through the process of chemotherapy is anticipated to fuel the adoption of PD-L1 biomarker testing among major healthcare facilities worldwide.

“Growing advancements in the field of oncology, along with accurate prediction insights offered by automated systems for biomarker testing will boost the sales of PD-L1 biomarker testing in the forthcoming years” says an FMI analyst.  

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Key Takeaways:

• Based on product, PD-L1 22C3 assay kits segment is projected to account for over 53% of the market share by 2032, with sales increasing at a 10.2% CAGR over the forecast period.
• In terms of indication, the NSCLS segment held 61.9% of the total market share in 2021, and the trend is expected to continue over the assessment period.
• By end user, sales in the cancer research institutes segment accounted for 43.2% of the total market share in 2021.

North America is slated to be the largest leading region with a value share of over 61%, spearheaded by the U.S.

• Sales in the U.K. will increase at a 10% CAGR over the assessment period.
• China will emerge as a lucrative market, with demand growing at a 10.9% CAGR over the forecast period.

Competition Landscape

Leading players operating in the market are actively working in coherence with researchers to be able to acquire enhanced and innovative concepts to widen the therapeutic actions of the product. For instance:

• In May 2020, F. Hoffman-La Roche AG acquired Stratos Genomics to develop DNA-based sequencing for diagnostic use.
• In July 2020, Abcam plc. and Cancer Research UK partnered for the development and commercialization of novel antibodies to accelerate cancer research.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global PD-L1 biomarker testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on PD-L1 biomarker testing market segment based on product (PD-L1 22C3 assay kit, PD-L1 28-8 assay kit, PD-L1 SP142 assay kit and PD-L1 263 assay kit), indication (NSCLS, melanoma, renal cell carcinoma, gastrointestinal tract malignancy, haematological malignancies, ovarian cancer and others), end user (hospitals, diagnostic laboratories and cancer research institutes) across seven major regions.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5897

Key Market Segments Covered In PD-L1 Biomarker Testing Industry Research

By Product:

• PD-L1 22C3 Assay Kit
• PD-L1 28-8 Assay Kit
• PD-L1 SP142 Assay Kit
• PD-L1 263 Assay Kit

By Indication:

• NSCLS
• Melanoma
• Renal Cell Carcinoma
• Gastrointestinal tract Malignancy
• Haematological Malignancies
• Ovarian Cancer
• Other

By End User:

• Hospitals
• Diagnostic Laboratories
• Cancer Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5897

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

PD-1/PD-L1 Inhibitors market Share is among the highest growing field in the pharmaceutical industry. PD-1/PD-L1 Inhibitors promise improved survival of patients, with low toxicity which is a huge market driving factor. The products available in the market for PD-1/PD-L1 inhibitors are increasingly meeting safety standards and are effective in the treatment of cancers. However, experts believe that the molecules in early clinical studies point towards safety concerns and high development cost can lead to high prices of the drug in the market which are a few challenged pharmaceutical companies have to encounter.

PD-1/PD-L1 Inhibitors Market: Region-wise Outlook

Based on geography, the PD-1/PD-L1 inhibitors market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the PD-1/PD-L1 inhibitors market followed by Europe. The major driving factors which have driven the growth of the PD-1/PD-L1 inhibitors market in these regions are constantly increasing the prevalence of various types of cancers, and demand for technologically advancements in the already successful approaches for treatment. The major companies are focusing on second generation therapies to improve the current treatment scenario with PD-1/PD-L1 inhibitors.
Following North America, European countries are also anticipated to show steady growth in the PD-1/PD-L1 inhibitors market. In the next few years, Asia-Pacific would show remarkable growth in the PD-1/PD-L1 inhibitors market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors which would fuel the growth of PD-1/PD-L1 inhibitors market in Asia-Pacific are increasing awareness regarding various types of cancers, increase the number of patients getting affected with the disease, and rapid development of the healthcare infrastructure across the Asian countries. PD-1/PD-L1 inhibitors market would evolve at a rapid rate across the regions. However, North America would maintain its position in the overall PD-1/PD-L1 inhibitors market.

PD-1/PD-L1 Inhibitors Market Overview

Immunotherapy treatment methods are evolving and are one of the prime methods for the treatment of cancer. PD-1/PD-L1 inhibitors have a targeted approach and decrease toxicity and hence resulting in increased efficacy. PD-1/PD-L1 inhibitors market is achieving advancements owing to the efficiency of the treatments.

PD-1/PD-L1 Inhibitors have been useful in the treatment of several cancers. PD-1/PD-L1 Inhibitors are being studies for the treatment of various type of cancers.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12644

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

PD-1/PD-L1 Inhibitors Market: Key Players

It is expected that with due course of time, there will be an entry of multiple pharmaceutical players in the PD-1/PD-L1 inhibitors market as PD-1/PD-L1 inhibitors have witnessed good investments from various key pharmaceutical companies. PD-1/PD-L1 inhibitors market currently has multiple ongoing deals and active research with many pharmaceutical companies looking to launch there products. Some of the top players operating in the PD-1/PD-L1 Inhibitors Market are Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene and many others.PD-1/PD-L1 Inhibitors Market has the presence of many regional players which have a huge market share in emerging countries.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12644

Key Segments:

By Product:

• Nivolumab
• Pembrolizumab
• Atezolizumab
• Avelumab
• Durvalumab

By Indication:

• Melanoma
• Non-Small Cell Lung Cancer (NSCLC)
• Renal Cell Carcinoma (RCC)
• Head and Neck Squamous Cell Cancer (HNSCC)
• Bladder Cancer
• Merkel Cell Carcinoma (MCC)
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle-East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12644

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Foley catheters  Market Size also known as urinary catheters, are flexible tubes that are passed through the urethra and bladder to facilitate easy drainage of urine. They are considered essential in the urology sector, aiding patients with bladder dysfunctions to drain urine into urine bags, and reducing urology-related complications. The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

• The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
• By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
• Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
• Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
• North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
• Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

 “With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

• C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
• B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
• In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-7769

Key Segments

Type:

• 2 Way
• 3 Way
• 4 Way

Material:

Latex Foley Catheter

• Hydrogel-Coated Latex Foley Catheters
• Silicon-Coated Latex Foley Catheter
• Silver-Coated Latex Foley Catheters
• “PTFE (polytetrafluoroethylene) (teflon)
• Coated Latex Foley Catheters

Silicon Foley Catheter

• Hydrogel-Coated Silicone Foley Catheters
• Pure Silicone Foley Catheters
• Silver Coated Silicon Foley Catheters
• Others

Indication:

•  Urinary Incontinence
•  Urethral Stricture
•  Chronic Obstruction
•  Neurogenic Bladder
•  Enlarged Prostate Gland/BPH
•  Prostate Cancer
•  Others

End-user:

• Hospitals
• Long Term Care Facilities
• Others

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-7769

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs